首页 | 本学科首页   官方微博 | 高级检索  
     

局部晚期鼻咽癌综合治疗研究进展
引用本文:高云生,胡超苏. 局部晚期鼻咽癌综合治疗研究进展[J]. 中国肿瘤临床, 2012, 39(24): 2044-2046. DOI: 10.3969/j.issn.1000-8179.2012.24.014
作者姓名:高云生  胡超苏
作者单位:复旦大学附属肿瘤医院放疗科, 复旦大学鼻咽癌诊治中心(上海市200032)
摘    要:局部晚期鼻咽癌的治疗以放、化综合治疗为主, 方案有诱导化疗、同期放化疗和辅助化疗及其不同的组合。同期放化疗(或加辅助化疗)是NCCN指南推荐的治疗方式。鼻咽癌的新辅助化疗虽然对提高总生存作用尚不肯定, 但是其高缓解率及减少远处转移的潜能, 可能使部分患者受益。含有紫杉类药物的新辅助化疗方案、靶向药物联合同期化疗亦成为临床研究的热点。 

关 键 词:鼻咽癌   放射治疗   化学治疗
收稿时间:2012-09-19

Combined Treatment of Loco-regionally Advanced Nasopharyngeal Carcinoma
Yunsheng GAO,Chaosu HU. Combined Treatment of Loco-regionally Advanced Nasopharyngeal Carcinoma[J]. Chinese Journal of Clinical Oncology, 2012, 39(24): 2044-2046. DOI: 10.3969/j.issn.1000-8179.2012.24.014
Authors:Yunsheng GAO  Chaosu HU
Affiliation:Department of Radiotherapy, Fudan University Cancer Hospital, Nasopharyngeal Carcinoma Center of Fudan University, Shanghai 200032, China
Abstract:Radiotherapies combined with chemotherapy, such as neo-adjuvant chemotherapy, concomitant chemo-radiotherapy, and adjuvant chemotherapy, are recommended in the treatment of loco-regionally advanced nasopharyngeal carcinoma(NPC).Concurrent chemo-radiotherapy is the standard treatment for advanced NPC.Although whether neo-adjuvant chemotherapy could improve the overall survival still remains uncertain, this treatment can increase the response rate and potentially eradicate the subclinical metastasis in patients with advanced NPC.The addition of paclitaxel and cisplatin-based neo-adjuvant chemotherapy has shown potential in terms of therapeutic efficacy and safety.The clinical trials of the neo-adjuvant chemotherapy combined with subsequent chemo-radiotherapy are more widely studied than independent radiotherapy and chemotherapy.Targeted therapy in combination with radiotherapy and chemotherapy is also popular in current studies. 
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号